Related references
Note: Only part of the references are listed.SGK1 in Human Cancer: Emerging Roles and Mechanisms
Yiwen Sang et al.
FRONTIERS IN ONCOLOGY (2021)
Talin1 Induces Epithelial-Mesenchymal Transition to Facilitate Endometrial Cell Migration and Invasion in Adenomyosis Under the Regulation of microRNA-145-5p
Yi-yi Wang et al.
REPRODUCTIVE SCIENCES (2021)
Serum- and Glucocorticoid-inducible Kinase 1 is Essential for Osteoclastogenesis and Promotes Breast Cancer Bone Metastasis
Zheng Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2020)
SGK1 activation exacerbates diet-induced obesity, metabolic syndrome and hypertension
Catalina Sierra-Ramos et al.
JOURNAL OF ENDOCRINOLOGY (2020)
High-Expression of Neuropilin 1 Correlates to Estrogen-Induced Epithelial-Mesenchymal Transition of Endometrial Cells in Adenomyosis
Rong Hu et al.
REPRODUCTIVE SCIENCES (2020)
TIPE2 inhibits the migration and invasion of endometrial cells by targeting β-catenin to reverse epithelial-mesenchymal transition
Yuqiu Liu et al.
HUMAN REPRODUCTION (2020)
The prospect of serum and glucocorticoid-inducible kinase 1 (SGK1) in cancer therapy: a rising star
Ruizhe Zhu et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
The small molecule SI113 hinders epithelial-to-mesenchymal transition and subverts cytoskeletal organization in human cancer cells
Claudia Abbruzzese et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
PI3K Inhibition Activates SGK1 via a Feedback Loop to Promote Chromatin-Based Regulation of ER-Dependent Gene Expression
Eneda Toska et al.
CELL REPORTS (2019)
A critical review of recent advances in the diagnosis, classification, and management of uterine adenomyosis
Justin Tan et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2019)
Transcriptome sequencing of adenomyosis eutopic endometrium: A new insight into its pathophysiology
Yuqian Xiang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Serum- and Glucocorticoid-induced Kinase Sgk1 Directly Promotes the Differentiation of Colorectal Cancer Cells and Restrains Metastasis
Lennard Y. W. Lee et al.
CLINICAL CANCER RESEARCH (2019)
The SGK1 inhibitor EMD638683, prevents Angiotensin II-induced cardiac inflammation and fibrosis by blocking NLRP3 inflammasome activation
Wenqiang Gan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
SGK1 inhibition-induced autophagy impairs prostate cancer metastasis by reversing EMT
Weiwei Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Berberine inhibits growth and inflammatory invasive phenotypes of ectopic stromal cells: Imply the possible treatment of adenomyosis
Li Liu et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2018)
Up-regulation of the kinase gene SGK1 by progesterone activates the AP-1-NDRG1 axis in both PR-positive and -negative breast cancer cells
Mukul Godbole et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Pathogenesis of adenomyosis: an update on molecular mechanisms
Silvia Vannuccini et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2017)
SGK1 Is a Critical Component of an AKT-Independent Pathway Essential for PI3K-Mediated Tumor Development and Maintenance
Arturo Orlacchio et al.
CANCER RESEARCH (2017)
Serum and Glucocorticoid Inducible Kinase 1-Sensitive Survival, Proliferation and Migration of Rhabdomyosarcoma Cells
Evi Schmid et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
The PI3K Pathway in Human Disease
David A. Fruman et al.
CELL (2017)
Estrogen receptor β regulates endometriotic cell survival through serum and glucocorticoid-regulated kinase activation
Diana Monsivais et al.
FERTILITY AND STERILITY (2016)
Lnc-SGK1 induced by Helicobacter pylori infection and high-salt diet promote Th2 and Th17 differentiation in human gastric cancer by SGK1/Jun B signaling
Yongliang Yao et al.
ONCOTARGET (2016)
An update on the pharmacological management of adenomyosis
Isabelle Streuli et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
In vivo collective cell migration requires an LPAR2-dependent increase in tissue fluidity
Sei Kuriyama et al.
JOURNAL OF CELL BIOLOGY (2014)
Elevated SGK1 predicts resistance of breast cancer cells to Akt inhibitors
Eeva M. Sommer et al.
BIOCHEMICAL JOURNAL (2013)
Serum and glucocorticoid inducible kinase, metabolic syndrome, inflammation, and tumor growth
Florian Lang et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2013)
The expression and functionality of stromal caveolin 1 in human adenomyosis
Linjie Zhao et al.
HUMAN REPRODUCTION (2013)
β-Catenin activation contributes to the pathogenesis of adenomyosis through epithelial-mesenchymal transition
Seo Jin Oh et al.
JOURNAL OF PATHOLOGY (2013)
Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis
Christoph Anacker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The pathophysiology of uterine adenomyosis: an update
Giuseppe Benagiano et al.
FERTILITY AND STERILITY (2012)
How common is adenomyosis? A prospective study of prevalence using transvaginal ultrasound in a gynaecology clinic
J. Naftalin et al.
HUMAN REPRODUCTION (2012)
The eutopic endometrium in endometriosis: are the changes of clinical significance?
Ivo Brosens et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2012)
EMD638683, a Novel SGK Inhibitor with Antihypertensive Potency
Teresa F. Ackermann et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2011)
Oestrogen-induced epithelial-mesenchymal transition of endometrial epithelial cells contributes to the development of adenomyosis
Yi-Jen Chen et al.
JOURNAL OF PATHOLOGY (2010)
The nuts and bolts of AGC protein kinases
Laura R. Pearce et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Administration of Glucocorticoids to Ovarian Cancer Patients Is Associated with Expression of the Anti-apoptotic Genes SGK1 and MKP1/DUSP1 in Ovarian Tissues
Amal Melhem et al.
CLINICAL CANCER RESEARCH (2009)
Targeting SGK1 in diabetes
Florian Lang et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Serurn/glucocorticoid-induced protein kinase-1 facilitates androgen receptor-dependent cell survival
I. Shanmugam et al.
CELL DEATH AND DIFFERENTIATION (2007)
Altered apoptosis and proliferation in endometrial stromal cells of women with adenomyosis
Jehn-Hsiahn Yang et al.
HUMAN REPRODUCTION (2007)
Structural basis of androgen receptor binding to selective androgen response elements
PL Shaffer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Adenomyosis - A result of disordered stromal differentiation
E Parrott et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)